Stanford
University
  • Stanford Home
  • Maps & Directions
  • Search Stanford
  • Emergency Info
  • Terms of Use
  • Privacy
  • Copyright
  • Trademarks
  • Non-Discrimination
  • Accessibility
© Stanford University.  Stanford, California 94305.
Implementation Challenges to Three Pillars of America’s AI Strategy | Stanford HAI

Stay Up To Date

Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.

Sign Up For Latest News

Navigate
  • About
  • Events
  • Careers
  • Search
Participate
  • Get Involved
  • Support HAI
  • Contact Us
Skip to content
  • About

    • About
    • People
    • Get Involved with HAI
    • Support HAI
    • Subscribe to Email
  • Research

    • Research
    • Fellowship Programs
    • Grants
    • Student Affinity Groups
    • Centers & Labs
    • Research Publications
    • Research Partners
  • Education

    • Education
    • Executive and Professional Education
    • Government and Policymakers
    • K-12
    • Stanford Students
  • Policy

    • Policy
    • Policy Publications
    • Policymaker Education
    • Student Opportunities
  • AI Index

    • AI Index
    • AI Index Report
    • Global Vibrancy Tool
    • People
  • News
  • Events
  • Industry
  • Centers & Labs
policyWhite Paper

Implementation Challenges to Three Pillars of America’s AI Strategy

Date
December 20, 2022
Topics
Government, Public Administration
Regulation, Policy, Governance
Read Paper
abstract

This white paper assesses the implementation status of three U.S. executive and legal actions related to AI innovation and trustworthy AI, calling for improvements in reporting and tracking key requirements.

In collaboration with

Executive Summary

This White Paper assesses the progress of three pillars of U.S. leadership in AI innovation and trustworthy AI that carry the force of law: (i) the AI in Government Act of 2020; (ii) the Executive Order on “AI Leadership”; and (iii) the Executive Order on “AI in Government.” Collectively, these Executive Orders and the AI in Government Act have been critical to defining the U.S. national strategy on AI and envisioning an ecosystem where the U.S. government leads in AI and promotes trustworthy AI. We systematically examined the implementation status of each requirement and performed a comprehensive search across 200+ federal agencies to assess implementation of key requirements to identify regulatory authorities pertaining to AI and to enumerate AI use cases.

While much progress has been made, our findings are sobering. America’s AI innovation ecosystem is threatened by weak and inconsistent implementation of these legal requirements. First, less than 40% of all requirements could be publicly verified as having been implemented. Second, 88% of examined agencies have failed to provide AI plans that identify regulatory authorities pertaining to AI. Third, roughly half or more of agencies have failed to file an inventory of AI use cases, as required under the AI in Government Order. Difficulties in verifying implementation strongly suggests that improvements must be made on reporting and tracking of requirements that the President or Congress deemed necessary for public disclosure. Fulfilling mandated transparency requirements strengthens external stakeholders’ ability to provide meaningful, informed advice to the federal government. The high prevalence of non-implementation suggests a leadership vacuum and capacity gap at the agency and national level. Agencies require leadership and resources and to meaningfully advance the objectives of these legal mandates. Checking these boxes is not the end itself, but is a mechanism for the ultimate goal of U.S. leadership and responsibility in AI development and trustworthy adoption, both for the public and private sector. Overall, implementation has been lacking.

Read Paper
Share
Link copied to clipboard!
Authors
  • Christie M. Lawrence
    Christie M. Lawrence
  • Isaac Cui
    Isaac Cui
  • Dan Ho headshot
    Daniel E. Ho

Related Publications

Response to OSTP's Request for Information on Accelerating the American Scientific Enterprise
Rishi Bommasani, John Etchemendy, Surya Ganguli, Daniel E. Ho, Guido Imbens, James Landay, Fei-Fei Li, Russell Wald
Quick ReadDec 26, 2025
Response to Request

Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.

Response to Request

Response to OSTP's Request for Information on Accelerating the American Scientific Enterprise

Rishi Bommasani, John Etchemendy, Surya Ganguli, Daniel E. Ho, Guido Imbens, James Landay, Fei-Fei Li, Russell Wald
Sciences (Social, Health, Biological, Physical)Regulation, Policy, GovernanceQuick ReadDec 26

Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.

Response to FDA's Request for Comment on AI-Enabled Medical Devices
Desmond C. Ong, Jared Moore, Nicole Martinez-Martin, Caroline Meinhardt, Eric Lin, William Agnew
Quick ReadDec 02, 2025
Response to Request

Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.

Response to Request

Response to FDA's Request for Comment on AI-Enabled Medical Devices

Desmond C. Ong, Jared Moore, Nicole Martinez-Martin, Caroline Meinhardt, Eric Lin, William Agnew
HealthcareRegulation, Policy, GovernanceQuick ReadDec 02

Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.

Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions
Russ Altman
Quick ReadOct 09, 2025
Testimony

In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.

Testimony

Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions

Russ Altman
HealthcareRegulation, Policy, GovernanceSciences (Social, Health, Biological, Physical)Quick ReadOct 09

In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.

Michelle M. Mello's Testimony Before the U.S. House Committee on Energy and Commerce Health Subcommittee
Michelle Mello
Quick ReadSep 02, 2025
Testimony

In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.

Testimony

Michelle M. Mello's Testimony Before the U.S. House Committee on Energy and Commerce Health Subcommittee

Michelle Mello
HealthcareRegulation, Policy, GovernanceQuick ReadSep 02

In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.